Anti IL-6 Inhibitor

Shakiri ELISA Kit is a recombinant, humanized, anti-human interleukin 6 (IL-6) receptor monoclonal antibody that achieves a significant therapeutic response rate, anti IL-6 inhibitor (injection) was further approved by the FDA for the treatment of adults with giant cell arteritis, an inflammation of the blood vessels (vasculitis) in May, 2017.

Anti IL-6 inhibitor  has been recently identify and is in use in the treatment of Covid-19 patients and the related clinical trial is ongoing in different centers.

If you are one of this center and need to measure the level of  the quantitative analysis of free anti IL-6 together with the qualitative determination of antibodies to IL-6 in serum and plasma samples Labospace is offering the possibility to run your samples in service or supply both ELISA kit CE-IVD labelled.

Interleukin-6 Human ELISA

  • Regulatory status:IVD CE
  • Type:Sandwich ELISA, Biotin-labelled antibody
  • Other names:IL-6, Interferon-beta 2, B-cell stimulatory factor 2,HGF
  • Species:Human
  • Cat. No. RD194015200R96 wells (1 kit)

PubMedProduct Details

Technical Data

Successful participation in EQA!

We are pleased to announce that we have successfully participated in the External Quality Assessment (RfB, survey of March 28, 2019), being involved in determination of IL-6.

Please find the Certificate in Docs or see article in RnD News.


Sandwich ELISA, Biotin-labelled antibody


Serum, Urine, Cerebrospinal fluid, Bronchoalveolar lavage, Amniotic fluid, Plasma, COVID-19


At ambient temperature. Upon receipt, store the product at the temperature recommended below.


Store the kit at 2–8°C. Under these conditions, the kit is stable until the expiration date (see label on the box).

Calibration Curve

Calibration Range

1.25 – 80 pg/ml

Limit of Detection

0.65 pg/ml

Intra-assay (Within-Run)

n = 8
CV = 4.7%

Inter-assay (Run-to-Run)

n = 6
CV = 4.9%

Spiking Recovery


Dilution Linearity

Serum = 91.2%
Urine = 93.3 %
CSF = 84.5%
Amniotic fluid = 99.4%